Can technology help us see the heart more clearly — and treat arrhythmias more effectively?
At Corify Care, we’re leading the ARTEMISA study, a collaboration bringing together top institutions to make that vision a reality.
ARTEMISA aims to develop the first integrated endo-epicardial mapping system, merging innovative technology, AI , and next-generation hardware to support precise, personalized ablation procedures.
The consortium includes:
- Corify Care
- Universitat Politècnica de València (UPV)
- Universidad Pública de Navarra (UPNA)
- Mondragon Components Competence Center (MC3)
- EMBEGA S. Coop
- Fundación para la Investigación Biomédica del Hospital Gregorio Marañón (FIBHGM).
Together, we will be developing:
⚙️ High-fidelity hardware and sensors that adapt to patient anatomy in real time.
⚙AI-driven software for 3D reconstruction of cardiac activity using digital twins.
⚙ A clinically validated system capable of identifying arrhythmia drivers with greater precision and enhancing therapeutic decision-making in real time.
This technology will have the potential to transform arrhythmia management — improving outcomes, reducing repeat procedures, and setting a new global benchmark for precision cardiology is our final goal: just take a look to our last visit to Estella!
Funded by the Spanish Ministry of Science, Innovation and Universities (MCIN) and the State Research Agency (AEI), and co-financed by the European Union – program with grant nº CPP2024-011368.
